These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7658816)

  • 41. Early medical abortion: a new regimen up to 49 days' gestation.
    Ashima T; Vinita A; Shalini R
    Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):137-9. PubMed ID: 15760315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medical termination of pregnancy.
    Christin-Maitre S; Bouchard P; Spitz IM
    N Engl J Med; 2000 Mar; 342(13):946-56. PubMed ID: 10738054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Outcomes and Women's Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa.
    Constant D; Harries J; Malaba T; Myer L; Patel M; Petro G; Grossman D
    PLoS One; 2016; 11(9):e0161843. PubMed ID: 27583448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outpatient medical abortion is safe and effective through 70 days gestation.
    Abbas D; Chong E; Raymond EG
    Contraception; 2015 Sep; 92(3):197-9. PubMed ID: 26118638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Timing and indication for curettage after medical abortion in early pregnant women with prior uterine incision.
    Wang G; Li D; Manconi F; Dong B; Zhang Y; Sun B
    Contraception; 2010 Jan; 81(1):62-6. PubMed ID: 20004275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The mifepristone-misoprostol regimen for early medical abortion.
    Ellertson C; Waldman SN
    Curr Womens Health Rep; 2001 Dec; 1(3):184-90. PubMed ID: 12112968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can women in less-developed countries use a simplified medical abortion regimen?
    Elul B; Hajri S; Ngoc NN; Ellertson C; Slama CB; Pearlman E; Winikoff B
    Lancet; 2001 May; 357(9266):1402-5. PubMed ID: 11356438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion.
    Schaff EA; Stadalius LS; Eisinger SH; Franks P
    J Fam Pract; 1997 Apr; 44(4):353-60. PubMed ID: 9108832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Minimal effective dose of mifepristone for medical abortion.
    Kapoor G; Salhan S; Sarda N; Aggarwal D
    J Indian Med Assoc; 2014 Feb; 112(2):96-9. PubMed ID: 25935963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of mifepristone and buccal misoprostol versus buccal misoprostol alone for medical abortion.
    Dahiya K; Ahuja K; Dhingra A; Duhan N; Nanda S
    Arch Gynecol Obstet; 2012 Apr; 285(4):1055-8. PubMed ID: 22009509
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early medical abortion with self-administered low-dose mifepristone in combination with misoprostol.
    Song LP; Tang SY; Li CL; Zhou LJ; Mo XT
    J Obstet Gynaecol Res; 2018 Sep; 44(9):1705-1711. PubMed ID: 29974571
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abortion induced with methotrexate and misoprostol.
    Wiebe ER
    CMAJ; 1996 Jan; 154(2):165-70. PubMed ID: 8548705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
    Honkanen H; Piaggio G; Hertzen H; Bártfai G; Erdenetungalag R; Gemzell-Danielsson K; Gopalan S; Horga M; Jerve F; Mittal S; Thi Nhu Ngoc N; Peregoudov A; Prasad RN; Pretnar-Darovec A; Shah RS; Song S; Tang OS; Wu SC;
    BJOG; 2004 Jul; 111(7):715-25. PubMed ID: 15198763
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A viable alternative to surgical vacuum aspiration: repeated doses of intravaginal misoprostol over 9 hours for medical termination of pregnancies up to eight weeks.
    Singh K; Fong YF; Dong F
    BJOG; 2003 Feb; 110(2):175-80. PubMed ID: 12618162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Updates to the US Food and Drug Administration Regulations for Mifepristone: Implications for Clinical Practice and Access to Abortion.
    Simmonds KE; Beal MW; Eagen-Torkko MK
    J Midwifery Womens Health; 2017 May; 62(3):348-352. PubMed ID: 28632953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Research on regimens for early medical abortion.
    von Hertzen H
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):133-6, 150. PubMed ID: 10846322
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days' LMP: a randomized controlled trial.
    Raghavan S; Comendant R; Digol I; Ungureanu S; Dondiuc I; Turcanu S; Winikoff B
    Contraception; 2010 Dec; 82(6):513-9. PubMed ID: 21074013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
    Faucher P; Baunot N; Madelenat P
    Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval in Second-Trimester Abortion: A Randomized Controlled Trial.
    Abbas DF; Blum J; Ngoc NT; Nga NT; Chi HT; Martin R; Winikoff B
    Obstet Gynecol; 2016 Nov; 128(5):1077-1083. PubMed ID: 27741182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.